Longevity 18 Plenary & Panel Speakers


Douglas Anderson FIA CERA FSA - Chief Visionary Officer.  Having developed the concept in the UK, and proven it in Canada, since 2018 DouglasDouglas Anderson has been focussing on establishing Club Vita US. The smarter collection and structuring of data enables more cost effective ways both to reduce the risks of financing in later life and to help our societies face up to the challenges of ageing populations. Before committing to an entrepreneurial life, Douglas practiced for thirty years as a consulting actuary, across a diverse spectrum of engagement s in the public and private sectors. He is a fellow of the UK’s Institute of Actuaries, the US’s Society of Actuaries and a Chartered Enterprise Risk Actuary.

Douglas passionately believes that the creation of an international longevity “currency” will increase the security of pension promises. Career wise, he has much unfinished business. To maximise his own longevity, he enjoys trail running, cycling and skiing. Douglas lives in London.

Baroness GREENFIELD Susan

Baroness Greenfield, Founder and CEO of Neuro-Bio Ltd (www.neuro-bio.com) is a neuroscientist, writer and broadcaster. She has published overBaroness Greenfield 200 papers in peer-reviewed journals, based mainly at Oxford University but has held research fellowships at the College de France Paris, NYU Medical Center New York and Melbourne University. She holds 32 honorary degrees from UK and foreign universities, has received numerous honours including the Legion d’Honneur from the French Government, an Honorary Fellowship from the Royal College of Physicians, The American Academy of Achievement Golden Plate Award, and The Australian Medical Research Society Medal. She is also a Fellow of the Royal Society of Edinburgh.


Amy Kessler is Senior Vice President and Head of International Reinsurance Strategic Initiatives at Prudential Financial.  Until 2021, she was theAmy Kessler founding leader of Prudential’s International Reinsurance business, which grew to $90 billion of profitable sales across five Amy Kesslerlines under her leadership. In 2011, she led Prudential's successful launch of its longevity reinsurance product and, together with her exceptional team, has closed over $95 billion in international reinsurance transactions since, covering members of nearly 200 pension funds in the United Kingdom including British Airways and Rolls-Royce.

Amy led the groundbreaking $27.7 billion captive longevity reinsurance transaction for British Telecom in 2014, which was named “Deal of the Year” by Risk magazine and earned Prudential top honors as “Reinsurer of the Year.” Amy’s leadership enabled Prudential to repeat as “Reinsurer of the Year” in 2015, 2016 and 2017 for continuous innovation in the reinsurance of pension and longevity risk.

With nearly 30 years of experience, Amy is an innovator whose work has helped pension funds proactively manage longevity risk and create retirement security for their members. She was chosen as one of the “2014 Women to Watch” by Business Insurance magazine, and she was named to Institutional Investor’s “Pension 40” list—a ranking of the 40 most influential people in pensions—in both 2014 and 2015. Amy possesses both capital markets expertise and in-depth insight into the innovative pension risk transfer transactions occurring globally. Before joining Prudential, Amy served as a principal at Bear Stearns and as Global Head of Pension ALM at Swiss Re in London.

Amy holds a Bachelor’s Degree in economics and a Master’s Degree in international economics and finance from Brandeis University, where she is the Co-Vice Chairperson of the Board of the International Business School and the 2013 recipient of the Dean’s Medal.

Prudential Financial Inc. (PFI) and its affiliated companies are not affiliated in any manner with Prudential plc (United Kingdom) or with Prudential Assurance Company, a subsidiary of M&G plc, incorporated in the United Kingdom.


Kirsty Maclean is a partner in the London office and member of the Corporate & Financial Services Department. Kirsty advises insurance, reinsuranceKirsty Maclean and other financial institution clients on a broad range of transactions and non-contentious matters. Kirsty has gained a reputation as a notable lawyer in the longevity and pension de-risking market, having advised European and US-based clients on many of the largest and highest-profile longevity transactions completed to date. Kirsty regularly advises on complex collateralised reinsurance transactions and has a particular focus on the interface between (re)insurance and the capital markets. Kirsty is recognised as “Up and Coming” by Chambers UK (2023) and as a “Next Generation Partner” by The Legal 500 UK (2023) for Insurance.

Prior to Willkie, Kirsty gained substantial experience working in-house in the insurance and reinsurance sectors. In particular, she advised Swiss Re's life and health structured transactions business in Europe and Asia.


Rohit Mathur leads Prudential’s International Reinsurance business, where he is responsible for the longevity risk transfer (LRT) and fundedRohit Mathur reinsurance businesses in the UK and Europe. Prudential's reinsurance activities have led the firm to being named “Reinsurer of the Year” for four consecutive years. The team has closed over $95 billion in longevity reinsurance transactions since 2011, covering members of nearly 200 pensionRohit Mathur funds in the United Kingdom including British Airways, HSBC, Marks and Spencer, and Rolls-Royce.

Prior to this role, Rohit was head of Global Product and Market Solutions, where he was charged with assessing the corporate finance implications of pension risk management to cultivate a consistent recognition of pension de-risking solutions. Partnering with Prudential's distribution team in the service of its clients, Rohit focused on promoting an understanding of pension risk issues among credit and equity analysts, treasurers, chief financial officers and investment bankers. Rohit has been involved in structuring and executing several large and innovative transactions in the United States, including the agreements with Kimberly-Clark Corporation, Philips and J.C. Penney to transfer pension liabilities.

Before joining Prudential, Rohit was an executive director and led the Capital Structure and Strategy advisory team for UBS Investment Bank. There, he advised clients in multiple industries, focusing specifically on corporate finance, risk advisory and pension issues. Prior to that, Rohit was with Moody's Investors Service, where he published research on accounting and pension issues and worked with credit analysts to incorporate those risks more systematically into company ratings. He also co-authored Moody's methodologies on assessing risk of multi-employer pensions and other post-retirement healthcare obligations.

Prudential Financial Inc. (PFI) and its affiliated companies are not affiliated in any manner with Prudential plc (United Kingdom) or with Prudential Assurance Company, a subsidiary of M&G plc, incorporated in the United Kingdom.


Professor Les Mayhew is Associate Head of Global Research at ILC and Professor of Statistics in the Faculty of Actuarial Science and Insurance atLes Mayhew Bayes Business School, the business school of City, University of London (formerly known as Cass Business School). He is an Honorary Fellow of the Faculty of Actuaries and a former senior civil servant, having worked for the Department of Health and Social Security, Department of Social Security and the Treasury where he was a Director in the Central Statistical Office and subsequently in the Office for National Statistics.  In 2009 he published a report entitled ‘Increasing longevity and the economic value of healthy ageing and working longer’ which was commissioned by the then Cabinet Office Strategy Unit. In his time at the International Institute of Applied Systems Analysis (IIASA) in Vienna in the early 2000s, he worked on global ageing, pensions and health care systems, co-authoring a book on the economics of population ageing in Japan, and was the first to produce forecasts warning of the global rise in health care costs due to population ageing.


Avery Michaelson is the Founder & CEO of Longitude Exchange, a digital marketplace dedicated to trading longevity risk, and Founding Partner ofAvery Michaelson Longitude Solutions, a transaction-oriented consultancy with expertise in longevity risk management. He has extensive experience in the longevity risk and insurance-linked securities markets having previously held positions at Société Générale and Deutsche Bank, with posts at Coventry and Peachtree in the Life Settlement market. Beyond his work in insurance, Avery has applied his passion for market-based solutions to the world of climate change by founding the green-tech company UCapture. Mr. Michaelson graduated Magna Cum Laude from the Wharton School at the University of Pennsylvania and is a frequent speaker at financial and longevity conferences.


S. Jay Olshansky received his Ph.D. in Sociology at the University of Chicago in 1984. He is a Professor in the School of Public Health at the University of Illinois at Chicago, Research Associate at the Center on Aging at the University of Chicago and Chief Scientist at LapetusS J Olshansky Solutions, Inc. -- a company that he co-founded. The focus of his research is on estimates of the upper limits to human longevity, exploring the health and public policy implications associated with individual and population aging, forecasts of the size, survival, and age structure of the population, pursuit of the scientific means to slow aging in people (The Longevity Dividend and Geroscience), and global implications of the re-emergence of infectious and parasitic diseases. During the last 39 years, Dr. Olshansky has been working with colleagues in the biological sciences to develop the modern "biodemographic paradigm" of mortality – an effort to understand the biological nature of the survival and dying out processes of living organisms. Dr. Olshansky is the first author of The Quest for Immortality: Science at the Frontiers of Aging (Norton, 2001); A Measured Breath of Life (2013); The Rise of Generians (2020); Pursuing Wealthspan (2020); and co-editor of Aging: The Longevity Dividend (Cold Spring Harbor Laboratory Press, 2015). An updated version of this book will be published in 2023. Dr. Olshansky's recent work is focused on linking the scientific study of aging with investments in longevity and mortality related products.  Dr. Olshansky is a Board member, American Federation of Aging Research (AFAR) and he served on the Board of Scientific Advisors at PepsiCo. In 2016, Dr. Olshansky was honored with the Donald P. Kent Award from the Gerontological Society of America, the Irving S. Wright Award from the American Federation for Aging Research, he was named a Next Avenue Influencer in Aging; and in 2017 he received the Alvar Svanborg Award. Dr. Olshansky received the Glenn Award from the Glenn Foundation for Medical Research in 2018. In 2022 Dr. Olshansky testified before the U.S. House Committee on Science, Space, and Technology on the topic of aging and Geroscience and how advances in aging biology are about to transform what it means to grow old.

RINKE Cord-Roland

Cord-Roland Rinke is Managing Director of Hannover Re - Life & Health Analytics and Longevity, which includes the global responsibility fCord_Roland_Rinkeor longevity business and a data analytics team. During the last years, Hannover Re has actively worked on transferring longevity risks from pension schemes and insurance companies onto its books. Cord and his team have written various longevity deals with a number of insurance carriers. His team has written business not only in the UK but also in North-America, Continental Europe and the Australian continent. Before that he was in charge of the life reassurance business in Asia and the annuity reassurance business in the UK. His team structured tailor-made life reassurance solutions for Hannover Re’s clients in the UK and the clients of the branch offices in Asia and Scandinavia. In the advent of Solvency II, he was also responsible for the corporate actuarial department building a life internal model for Solvency II and managing the calculation of Hannover Re’s market consistent embedded value. He joined Hannover Re in 1990. In the middle of the 1990s he was largely involved in the establishment of Impaired Live Annuities and Enhanced Annuities in the UK. Since then Hannover Re has successfully become the market leader in the reassurance of UK Enhanced Annuities. Cord holds a degree in Mathematics, is a member of the Deutsche Aktuar Vereinigung and a Fellow of the Society of Actuaries.

TITON Eve Elizabeth

Member of the French Institute of Actuaries since 2017, Eve is a Senior Consultant in the R&D department of Milliman Paris. She handles numerousEve Triton technical and R&D assignments covering a wide range of risks, including: mortality, health/pension, reserving and rating models for credit risk. Eve is also involved in research on current topics such as climate risks, the impact of connected objects on health, cyber risks, and individual reserving models.